Synovial fluid cytokines and eicosanoids as markers of joint disease in horses.
Authors: Bertone A L, Palmer J L, Jones J
Journal: Veterinary surgery : VS
Summary
# Editorial Summary: Synovial Fluid Biomarkers for Equine Joint Disease Bertone and colleagues assessed whether inflammatory mediators in synovial fluid could reliably diagnose joint disease in horses, hypothesising that cytokines and eicosanoids might provide objective diagnostic markers when clinical presentation is ambiguous or lameness intermittent. The researchers measured seven inflammatory mediators—TNF-α, IL-1β, IL-6, PGE₂, TXB₂, PGF₁-α, and LTB₄—in synovial fluid samples from 119 joints (50 normal, 28 acutely diseased, 32 chronically diseased, and 9 with isolated cartilage damage), establishing operating point thresholds and calculating sensitivity, specificity, and predictive values for each marker. IL-6 emerged as an excellent screening test, with even trace concentrations indicating pathology and strong correlation to synovial white blood cell counts; PGE₂ also performed excellently at concentrations above 22.5 pg/mL and notably was not confounded by cellularity; conversely, TNF-α and IL-1β offered no advantage over routine cell counts. Most clinically compelling, PGF₁-α concentrations exceeding 16.5 pg/mL demonstrated exceptional sensitivity and specificity (1.0 and 0.89 respectively) for severe chronic joint disease, potentially identifying significant cartilage degradation even when radiographic changes remain subtle. For practitioners, these findings suggest synovial fluid IL-6 analysis could provide valuable objective confirmation of joint disease when clinical diagnosis is unclear, whilst PGF₁-α assessment may help differentiate subtle chronic pathology—particularly useful in performance horses where early intervention might preserve function
Read the full abstract on PubMed
Practical Takeaways
- •IL-6 and PGE(2) synovial fluid measurements offer objective biomarkers for diagnosing joint disease when lameness is subtle or intermittent, potentially improving early detection
- •PGF(1)-alpha elevation (>16.5 pg/mL) may help identify chronic degenerative joint disease with significant cartilage damage even when radiographic changes are minimal
- •Synovial fluid cytokine/eicosanoid analysis could supplement joint flexion tests and imaging in clinical cases where joint involvement is suspected but not radiographically evident
Key Findings
- •IL-6 was an excellent predictor of joint disease with any detectable concentration indicating disease presence and high correlation with synovial fluid WBC (P<0.0001)
- •PGE(2) concentration >22.5 pg/mL was a good-excellent predictor of joint disease (PPV=0.75) independent of WBC count
- •PGF(1)-alpha >16.5 pg/mL identified chronic severe joint disease with perfect sensitivity (S=1.0) and high specificity (Sp=0.89)
- •TNF-alpha and IL-1beta were no more effective than WBC count alone for screening joint disease